References
- Jaffer FA, Weissleder R. Molecular imaging in the clinical arena. JAMA. 2005; 293:855-62. https://doi.org/10.1001/jama.293.7.855
- Koh D-M, Cook GJ, Husband JE. New horizons in oncologic imaging. N Engl J Med. 2003;348:2487-8. https://doi.org/10.1056/NEJMp030048
- Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev. 1999;99: 2293-352. https://doi.org/10.1021/cr980440x
- Li Y, Beija M, Laurent S, Elst LV, Muller RN, Duong HT, Lowe AB, Davis TP, Boyer C. Macromolecular ligands for gadolinium MRI contrast agents. Macromolecules. 2012;45:4196-204. https://doi.org/10.1002/chem.200204612
- Lim J, Turkbey B, Bernardo M, Bryant LH Jr, Garzoni M, Pavan GM, Nakajima T, Choyke PL, Simanek EE, Kobayashi H. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics. Bioconjug Chem. 2012;23:2291-9. https://doi.org/10.1021/bc300461r
- Raymond KN, Pierre VC. Next generation, high relaxivity gadolinium MRI agents. Bioconjug Chem. 2005;16:3-8. https://doi.org/10.1021/bc049817y
- Hooker JM, Datta A, Botta M, Raymond KN, Francis MB. Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. Nano Lett. 2007;7:2207-10. https://doi.org/10.1021/nl070512c
- Song Y, Xu X, MacRenaris KW, Zhang XQ, Mirkin CA, Meade TJ. Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. Angew Chem Int Ed. 2009;48:9143-7. https://doi.org/10.1002/anie.200904666
- Ward K, Aletras A, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson. 2000;143:79-87. https://doi.org/10.1006/jmre.1999.1956
- Werner EJ, Datta A, Jocher CJ, Raymond KN. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew Chem Int Ed. 2008;47:8568-80. https://doi.org/10.1002/anie.200800212
- Chen W, Vucic E, Leupold E, Mulder WJ, Cormode DP, Briley-Saebo KC, Barazza A, Fisher EA, Dathe M, Fayad ZA. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Contrast Media Mol Imaging. 2008;3:233-42. https://doi.org/10.1002/cmmi.257
- Corot C, Robert P, Lancelot E, Prigent P, Ballet S, Guilbert I, Raynaud JS, Raynal I, Port M. Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting. Magn Reson Med. 2008;60: 1337-46. https://doi.org/10.1002/mrm.21773
- Kim KS, Park W, Hu J, Bae YH, Na K. A cancer-recognizable MRI contrast agents using pH-responsive polymeric micelle. Biomaterials. 2014;35:337-43. https://doi.org/10.1016/j.biomaterials.2013.10.004
- Konda SD, Aref M, Wang S, Brechbiel M, Wiener EC. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. MAGMA. 2001;12:104-13. https://doi.org/10.1007/BF02668091
- Shu C-Y, Ma X-Y, Zhang J-F, Corwin FD, Sim JH, Zhang E-Y, Dorn HC, Gibson HW, Fatouros PP, Wang C-R. Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent. Bioconjug Chem. 2008;19:651-5. https://doi.org/10.1021/bc7002742
- Yim H, Yang S-G, Jeon YS, Park IS, Kim M, Lee DH, Bae YH, Na K. The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI. Biomaterials. 2011;32:5187-94. https://doi.org/10.1016/j.biomaterials.2011.03.069
- Datta A, Raymond KN. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents. Acc Chem Res. 2009;42: 938-47. https://doi.org/10.1021/ar800250h
- Pierre VC, Botta M, Raymond KN. Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength. J Am Chem Soc. 2005;127:504-5. https://doi.org/10.1021/ja045263y
- Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21:1104-8. https://doi.org/10.1093/ndt/gfk062
- Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007;242:647-9. https://doi.org/10.1148/radiol.2423061640
- Thomson LK, Thomson PC, Kingsmore DB, Blessing K, Daly CD, Cowper SE, Roditi GH. Diagnosing nephrogenic systemic fibrosis in the post-FDA restriction era. J Magn Reson Imaging. 2015;41:1268-71. https://doi.org/10.1002/jmri.24664
- Daram SR, Cortese CM, Bastani B. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis. 2005;46:754-9. https://doi.org/10.1053/j.ajkd.2005.06.024
- Thomsen HS, Morcos SK, Almen T, Bellin M-F, Bertolotto M, Bongartz G, Clement O, Leander P, Heinz-Peer G, Reimer P. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR contrast medium safety committee guidelines. Eur Radiol. 2013;23:307-18. https://doi.org/10.1007/s00330-012-2597-9
- Grogna M, Cloots R, Luxen A, Jerome C, Desreux J-F, Detrembleur C. Design and synthesis of novel DOTA (Gd 3+)-polymer conjugates as potential MRI contrast agents. J Mater Chem. 2011;21:12917-26. https://doi.org/10.1039/C1JM00005E
- Barge A, Cravotto G, Gianolio E, Fedeli F. How to determine free Gd and free ligand in solution of Gd chelates. A technical note. Contrast Media Mol Imaging. 2006;1:184-8. https://doi.org/10.1002/cmmi.110
Cited by
- Application of black phosphorus nanodots to live cell imaging vol.22, pp.1, 2018, https://doi.org/10.1186/s40824-018-0142-x
- Fluorinated MRI contrast agents and their versatile applications in the biomedical field vol.11, pp.10, 2018, https://doi.org/10.4155/fmc-2018-0463
- The Transition from Metal-Based to Metal-Free Contrast Agents for T1 Magnetic Resonance Imaging Enhancement vol.30, pp.9, 2019, https://doi.org/10.1021/acs.bioconjchem.9b00499
- Magnetic nanoparticles applied in targeted therapy and magnetic resonance imaging: crucial preparation parameters, indispensable pre-treatments, updated research advancements and future perspectives vol.8, pp.28, 2020, https://doi.org/10.1039/d0tb00552e
- A Gadolinium DO3A Amide m-Phenyl Boronic Acid MRI Probe for Targeted Imaging of Sialated Solid Tumors vol.9, pp.10, 2018, https://doi.org/10.3390/biomedicines9101459
- Influence of polyethylene glycol on the physical properties of Co0.2Fe2.8O4 nanoparticles used as MRI contrast agent; synchrotron radiation Fe K-edge XAFS vol.15, pp.None, 2018, https://doi.org/10.1016/j.jmrt.2021.09.143